Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by slowing stomach emptying and reducing appetite through GLP-1 receptor activation in the brain. The medication requires a structured dosing schedule that typically spans 16 to 20 weeks, starting at 0.25 mg and increasing by 0.25 mg increments each week until reaching an effective maintenance dose. Understanding this titration process helps patients anticipate changes and manage expectations throughout their weight loss journey.
Understanding Semaglutide Dose Titration and Weekly Increases
Semaglutide dosing begins conservatively to allow your body to adapt to the medication's effects. The initial 0.25 mg dose is subtherapeutic—meaning it's below the dose needed for maximum weight loss benefit—but serves a critical purpose: establishing tolerance and reducing nausea, vomiting, and gastrointestinal discomfort that some patients experience. Clinical trials show that gradual titration improves medication adherence and reduces discontinuation due to side effects.
Each week, patients increase their dose by 0.25 mg, progressing through 0.5 mg, 0.75 mg, and 1.0 mg during the first month. This slow escalation gives your digestive system and nervous system time to adjust to semaglutide's mechanism of action. Most patients reach their target maintenance dose of 1.0 mg or 2.4 mg by week 16 to 20, depending on clinical response and tolerability.
Maintenance Doses and Finding Your Effective Treatment Level
Once your body tolerates semaglutide, your healthcare provider identifies the dose that produces meaningful appetite suppression and weight loss without intolerable side effects. The standard maintenance dose is 1.0 mg weekly, though some patients benefit from continuing to 1.7 mg or 2.4 mg. Clinical data from the STEP trials (Semaglutide Treatment Effect in People with obesity) demonstrated that higher doses correlate with greater weight loss: patients on 2.4 mg saw average reductions of 21.4% of body weight over 68 weeks compared to 5.2% on placebo.
Individual factors influence your ideal dose, including starting weight, metabolic health, concurrent medications, and genetic predisposition to GLP-1 receptor sensitivity. PlexusDx offers the Precision Peptide Genetic Test, which maps your GLP1R rs6923761 variant and 48 other peptide-pathway markers to help predict your response to semaglutide. This personalization reduces trial-and-error and accelerates your path to an effective dose.
Managing Common Side Effects During Dose Escalation
Nausea and gastrointestinal symptoms are the most frequent side effects during the dose titration phase, occurring in up to 40% of patients in early weeks. These symptoms typically peak during the first two weeks after a dose increase and diminish within 3 to 5 days as your body adapts. Eating smaller, low-fat meals; staying hydrated; and slowing your eating pace can significantly reduce nausea severity and duration.
If side effects become unbearable, patients and their providers can pause at a lower dose for an additional week or two before advancing, extending the titration timeline slightly. This modified approach maintains tolerance while still progressing toward therapeutic benefit. Importantly, side effects are not indicators of medication failure—they reflect the drug's pharmacological action on appetite and satiety centers in your brain.
PlexusDx Semaglutide Dosing: Transparent Pricing and Personalized Support
PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies across all 50 states, starting at just $149 per month. Your dose may need to go up as you progress through titration, but your price will not—PlexusDx maintains flat monthly rates regardless of whether you're at 0.25 mg, 1.0 mg, or 2.4 mg. This pricing model eliminates the cost barriers many patients face when advancing their therapy, ensuring financial predictability throughout your treatment journey.
PlexusDx pairs semaglutide therapy with optional genetic testing through the Precision Peptide Genetic Test ($99 add-on after your first month). This test examines your GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 variants, revealing your peptide-pathway predispositions and informing dose recommendations. No insurance is required, HSA and FSA funds are accepted, and no membership fees apply.
Dose Adjustments: When and How Your Provider May Change Your Regimen
After reaching your target maintenance dose, your healthcare provider monitors your weight loss trajectory, appetite suppression, and side effect profile. If you plateau—meaning your weight loss stalls for more than 4 weeks—your provider may recommend increasing your dose by 0.25 mg to 0.5 mg increments. Conversely, if side effects worsen or become intolerable, a temporary dose reduction (stepping down 0.25 mg) followed by re-titration at a slower pace may restore tolerability.
Long-term semaglutide therapy typically continues at a stable dose for 6 to 12 months before reassessment. Some patients maintain their weight on lower doses; others sustain progress on higher doses. Regular check-ins with your PlexusDx provider ensure your dose remains aligned with your evolving health goals, body composition, and medication tolerance profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the standard starting dose of semaglutide, and why is it so low?
The standard starting dose is 0.25 mg injected weekly. This low dose allows your gastrointestinal system and nervous system to adapt to semaglutide's GLP-1 receptor signaling, minimizing early nausea and vomiting while building tolerance. Clinical evidence shows that gradual titration improves long-term adherence and patient satisfaction compared to higher starting doses.
How long does the entire semaglutide titration process take?
Most patients complete the standard 16-week titration schedule, increasing by 0.25 mg each week until reaching 1.0 mg or 2.4 mg. However, if you experience significant side effects or need additional adaptation time, your provider can extend the timeline by pausing at a given dose for 1 to 2 additional weeks before advancing, which may stretch titration to 20 weeks or longer.
Does my semaglutide price change if I increase my dose at PlexusDx?
No. PlexusDx charges a flat monthly rate for compounded semaglutide injections starting at $149/month, regardless of your current dose. Your dose may need to go up as you progress through titration or adjust your therapy, but your price will not—ensuring transparent, predictable costs throughout your treatment.
What should I do if I experience severe nausea during dose escalation?
Contact your PlexusDx provider to discuss your symptoms. Common strategies include eating smaller, low-fat meals; staying well-hydrated; and slowing your eating pace. If nausea persists, your provider may recommend delaying your next dose increase for 1 to 2 weeks, allowing more adaptation time. Severe nausea rarely requires stopping treatment and usually resolves within 3 to 5 days of dose adjustment.
How does PlexusDx's Precision Peptide Genetic Test help with semaglutide dosing?
The Precision Peptide Genetic Test ($99 add-on) examines your GLP1R rs6923761 variant and 48 other peptide-pathway markers across 14 biological pathways. This analysis reveals your inherent GLP-1 receptor sensitivity and metabolic predispositions, helping your PlexusDx provider personalize your dose recommendations and predict whether you'll respond optimally to standard doses or may benefit from higher or lower titration paths.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Why Does My Ozempic Injection Site Burn: Causes and Solutions
Why Does It Burn When I Inject Ozempic? Understanding Injection Site Reactions